CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AXGN | Axogen INC | Stock-Other | 29.64% | — | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 25.90% | — | — | |
| 3 | ✓ | Corium Intl INC | Stock-Other | 23.48% | — | — | |
| 4 | ABMDEUR | Abiomed INC | Stock-Other | 12.85% | — | -68.80% | |
| 5 | MNOV | Medicinova INC | Stock-Other | 2.62% | +0.14% | — | |
| 6 | ✓ | Endologix INC | Stock-Other | 2.53% | — | — | |
| 7 | ✓ | Psivida CORP | Stock-Other | 2.30% | — | — | |
| 8 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.46% | — | — | |
| 9 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.22% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AXGN | Axogen INC | +10.7% | — | Unchanged |
| 2 | ✓ | Corium Intl INC | +7.2% | — | Unchanged |
| 3 | MNOV | Medicinova INC | +1.3% | — | Unchanged |
| 4 | RVNCEUR | Revance Therapeutics INC | +1.1% | — | Unchanged |
| 5 | ✓ | Catalyst Biosciences INC | +0.3% | — | Unchanged |
| 6 | ✓ | Endologix INC | +0.2% | — | Unchanged |
| 7 | ACUR | Acura Pharmaceuticals INC | +0.1% | — | Unchanged |
| 8 | ABMDEUR | Abiomed INC | -9.1% | -68.80% | Trim |
| 9 | ✓ | Entellus Medical INC | — | EXIT | Sold out |
| 10 | ✓ | Psivida CORP | — | NEW | New buy |